Drug Resistance and Sensitivity Network (DRSN)
Drug Resistance and
Sensitivity Network
Toggle Menu
Drug Resistance and
Sensitivity Network
About
Featured Talk
Background
Organization
White Paper
Members
DRSN Research Centers
DRSN Supplement Projects
DRSN Revision Projects
DRSN Coordination Center
Working Groups
DRSN Working Groups
Organoid Bulletin Board
Funding
ARTNet (next phase of DRSN)
DRSN Administrative Supplement
DRSN Revision Application
Events
DRSN Event Calendar
Upcoming Webinars
Cancer Moonshotâ„ Seminar Series
Computational Immuno-oncology Webinars
Workshop on Immunomodulatory Agents
Past Events
Publications
DRSN Reviews
Resources
All Resources
Policy
Data
Model
Software
Clinical Trial
Education
2022 Publications (1)
Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.
Damnernsawad A, Bottomly D, Kurtz SE, Eide CA, McWeeney SK, Tyner JW, Nechiporuk T.
Haematologica. 2022 Jan 01. 1(107).